| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $2.48 (Beat by $0.17) |
| EPS GAAP Actual | $2.48 (Beat by $0.17) |
| Revenue Actual | $3.96695B |
| Revenue Surprise | Beat by $3966.95M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 11.91 | 21.76 | 11.72262 | 12.10521 | 1 |
| Dec 2028 | 7.53 | 34.42 | 7.20511 | 7.74381 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.07 | 2.07 | 3.96695B | 18.01% | 3966.95M |
| FQ2 2025 (Jun 2025) | 1.1 | 1.1 | 3.54471B | 16.46% | 3544.71M |
| FQ1 2025 (Mar 2025) | 0.13 | 0.13 | 2.84772B | 5.65% | 2847.72M |
| FQ4 2024 (Dec 2024) | 0.96 | 0.96 | 3.4031B | 3.61% | 3403.1M |
| FQ3 2024 (Sep 2024) | 1.22 | 1.22 | 3.25243B | -0.14% | 3252.43M |
| FQ2 2024 (Jun 2024) | 1.06 | 1.06 | 2.96109B | 2.94% | 2961.09M |
| FQ1 2024 (Mar 2024) | -0.53 | -0.53 | 2.68685B | 3.8% | 2686.85M |
| FQ4 2023 (Dec 2023) | 0.0096 | 0.0096 | 3.28008B | 100% | 3280.08M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2030 (Sep 2030) | 5.6145 | -- | 5.2659 | 6.03232 | 2 |
| FQ2 2030 (Jun 2030) | 4.3023 | -- | 4.03517 | 4.62247 | 2 |
| FQ1 2030 (Mar 2030) | 2.4293 | -- | 2.27847 | 2.61008 | 2 |
| FQ4 2029 (Dec 2029) | 3.8089 | -- | 3.75788 | 3.85724 | 3 |
| FQ3 2029 (Sep 2029) | 3.6329 | -- | 3.42437 | 3.8852 | 3 |
| FQ2 2029 (Jun 2029) | 2.9747 | -- | 2.80395 | 3.18129 | 3 |
| FQ1 2029 (Mar 2029) | 1.7392 | -- | 1.63937 | 1.85999 | 3 |
| FQ4 2028 (Dec 2028) | 2.1984 | -- | 2.13253 | 2.23889 | 5 |
| FQ3 2028 (Sep 2028) | 2.7113 | -- | 2.63007 | 2.76123 | 4 |
| FQ2 2028 (Jun 2028) | 2.0125 | -- | 1.9522 | 2.04956 | 5 |
| FQ1 2028 (Mar 2028) | 0.834 | -- | 0.80901 | 0.84936 | 4 |
| FQ4 2027 (Dec 2027) | 1.9166 | -- | 1.85918 | 1.9519 | 4 |
| FQ3 2027 (Sep 2027) | 2.4408 | -- | 2.36767 | 2.48575 | 3 |
| FQ2 2027 (Jun 2027) | 1.7828 | -- | 1.72938 | 1.81563 | 4 |
| FQ1 2027 (Mar 2027) | 0.93749 | -- | 0.93749 | 0.93749 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2030 (Sep 2030) | 9.27B | -- | 8.83B | 9.8B | 3 |
| FQ2 2030 (Jun 2030) | 8.89B | -- | 8.46B | 9.39B | 3 |
| FQ1 2030 (Mar 2030) | 8.52B | -- | 8.11B | 9B | 3 |
| FQ4 2029 (Dec 2029) | 5.03B | -- | 4.98B | 5.08B | 5 |
| FQ3 2029 (Sep 2029) | 6.5B | -- | 6.22B | 6.85B | 4 |
| FQ2 2029 (Jun 2029) | 6.28B | -- | 6B | 6.62B | 4 |
| FQ1 2029 (Mar 2029) | 6.07B | -- | 5.8B | 6.39B | 4 |
| FQ4 2028 (Dec 2028) | 5.52B | -- | 5.4B | 5.6B | 1 |
| FQ3 2028 (Sep 2028) | 5.34B | -- | 5.21B | 5.41B | 1 |
| FQ2 2028 (Jun 2028) | 5.15B | -- | 5.04B | 5.23B | 1 |
| FQ1 2028 (Mar 2028) | 4.98B | -- | 4.86B | 5.05B | 1 |
| FQ4 2027 (Dec 2027) | 4.81B | -- | 4.7B | 4.88B | 2 |
| FQ3 2027 (Sep 2027) | 4.65B | -- | 4.54B | 4.71B | 2 |
| FQ2 2027 (Jun 2027) | 4.49B | -- | 4.38B | 4.55B | 2 |
| FQ1 2027 (Mar 2027) | 3.15B | -- | 3.15B | 3.15B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.07 | 2.07 | 100% | |
| FQ2 2025 (Jun 2025) | 1.1 | 1.1 | 100% | |
| FQ1 2025 (Mar 2025) | 0.13 | 0.13 | 100% | |
| FQ4 2024 (Dec 2024) | 0.96 | 0.96 | 100% | |
| FQ3 2024 (Sep 2024) | 1.22 | 1.22 | 100% | |
| FQ2 2024 (Jun 2024) | 1.06 | 1.06 | 100% | |
| FQ1 2024 (Mar 2024) | -0.53 | -0.53 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0096 | 0.0096 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $3.97B | $3966.95M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $3.54B | $3544.71M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.85B | $2847.72M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.4B | $3403.1M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.25B | $3252.43M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.96B | $2961.09M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.69B | $2686.85M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.28B | $3280.08M | 100% |